Validation of the TNM classification (6th ed. / 2003) in the staging of small-cell lung cancer (SCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 163s Year: 2003
Screening for incidence of lung cancer (LC) among the patients with pulmonary pathology (with special reference to histological subtype and TNM-staging system) in Ukraine Source: Eur Respir J 2005; 26: Suppl. 49, 537s Year: 2005
Sleeve-pneumonectomy for lung cancer – survival and complications (update 2005) Source: Eur Respir J 2005; 26: Suppl. 49, 492s Year: 2005
Lung cancer in Berlin – NET of the lung; analysis of subgroups and impact on survival (2000 – 2008) Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013
Comparative epidemiology of lung cancer (prevalence, histology, stage at diagnosis and resectability rate) in North Teesside (UK) and in the Province of Varese (Italy) Source: Eur Respir J 2001; 18: Suppl. 33, 477s Year: 2001
Time to diagnosis and time to therapy in patients with malignant pleural mesothelioma (MPM) compared to patients with lung cancer in Denmark 2007 to 2011. A quality assurance analysis Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012
The analysis of lung cancer patients (LCP) survival during 5 year period after diagnosis of disease Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006
Use of Bode index (BI) in patients with COPD undergoing inpatient pulmonary rehabilitation (IPR) after lung resection (LR) for non small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 70s Year: 2006
Survival of patients resected for lung cancer in the period 1986 - 1977. Sensitivity of staging, prognostic factors, impact of adjuvant chemotherapy and radiotherapy Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001
Specific features of small cell lung cancer in women: social characteristics, medical history, management and survival. A retrospective study of the 967 cases diagnosed in Bas-Rhin (Eastern France) between 1981 and 1994 Source: Eur Respir J 2002; 20: Suppl. 38, 187s Year: 2002
Comparative analysis of lung malignant tumors (LMT) incidence in 1999 and 2004 Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006
The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients. Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017
A new TNM classification is better than ISS at predicting survival in stage III unresectable non-small cell lung cancer (NSCLC). A study by the European lung cancer working party (ELCWP) Source: Eur Respir J 2003; 22: Suppl. 45, 163s Year: 2003
Oncogenic drivers (OD) and matched targeted agents (TA): Impact on overall survival in patients with lung adenocarcinoma (LA)? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
June 4: Ebus in staging lung cancer Source: Year: 2008
Response to cancer chemotherapy (CTh) in patients (pts) with non-small cell lung cancer (NSCLC) according to their serum levels of chosen tumor markers (CYFRA 21-1 (CY21), CEA and NSE) Source: Eur Respir J 2001; 18: Suppl. 33, 377s Year: 2001
Expression of D2-40 in small cell lung carcinomas (SCLC); Association with lymphatic invasion(L.I), clinical parameters and prognosis Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010
Lung cancer in Berlin – Therapeutic concepts and their impact on survival in patients with NSCLC stage II/III from 2000 to 2008 Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Muldisciplinary conference (MDC), oncological program (OP) and practice guidelines (GL): The experience of the lung cancer (LC) clinic of a cancer hospital Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014
A statistical model to estimate lung density (LD) utilizing oscillometry (OS), biometrics (BM), patient reported outcomes (PRO) and pulmonary function tests (PFT) Source: International Congress 2016 – The future of lung function is beginning now Year: 2016